3 articles
Bayer AG sold a minority stake in its contraceptives business to Apollo Global Management for €3 billion to help cover Roundup litigation costs, while retaining operational control over key products l
Bayer AG reported Q1 earnings beating estimates, driven by crop science gains from soybean seeds and herbicide approvals. Despite pharmaceutical sales declines, the company upheld its full-year outloo
Bayer AG and BP PLC formed a strategic alliance to scale camelina production for biofuels, targeting North America first. The collaboration leverages Bayer's seed technology and BP's refining expertis
ChemBrief